Vikas Lifecare Ltd

Vikas Lifecare Other Announcement

Vikas Lifecare Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.

Vikas Lifecare Annual General Meeting

Vikas Lifecare obtained ROC approval to extend its FY26 AGM by 2 months and 28 days. The new AGM date will be communicated once finalised by the Board.

Vikas Lifecare Other Announcement

Vikas Lifecare Limited has applied to the Registrar of Companies for an extension of time to convene its Annual General Meeting for FY 2025-26.

Vikas Lifecare ED Probe / Tax Survey

Vikas Lifecare promoter Vikas Garg was taken into custody by the Directorate of Enforcement. The company states there is currently no material impact on business operations.

Vikas Lifecare Board Meeting Outcome

Vikas Lifecare approved its audited standalone and consolidated financial results for FY26. The auditor's report highlights qualified opinions and various emphasis of matter items.

Vikas Lifecare Q4 FY26 Results: Turns Profitable, Net Profit ₹41.6 Cr

Vikas Lifecare Ltd reported revenue from operations of ₹168.6 Cr (+24.7% YoY) and net profit of ₹41.6 Cr for Q4 FY26.

Key figure

Net profit ₹41.6 Cr

Vikas Lifecare Other Announcement

Vikas Lifecare Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The report notes ₹0.12 Crore in historical fines for various listing regulation filing delays.

Value

₹0.12 Cr

Vikas Lifecare Annual General Meeting

Vikas Lifecare shareholders approved the issuance of 61.90 Crore warrants and an increase in authorized share capital. All three postal ballot resolutions passed with requisite majority.

Vikas Lifecare Annual General Meeting

Vikas Lifecare shareholders approved resolutions for warrant issuance and authorized capital increases via postal ballot. All items passed with requisite majority as per scrutinizer reports.

Vikas Lifecare Q2 FY26 Results: Net Loss of ₹119 Cr

Vikas Lifecare Limited approved un-audited financial results for the periods ended September 30 and December 31, 2025. Standalone total income for the half-year ended September 2025 stood at ₹363.10 Crore. The board also approved seeking member consent via a postal ballot addendum for related party transactions and investments.

Key figure

Net loss ₹119 Cr

Vikas Lifecare Financial Results

Vikas Lifecare Limited approved un-audited financial results for the periods ended September 30 and December 31, 2025. Standalone total income for the half-year ended September 2025 stood at ₹363.10 Crore. The board also approved seeking member consent via a postal ballot addendum for related party transactions and investments.

Value

₹363.1 Cr

Vikas Lifecare Annual General Meeting

Vikas Lifecare Limited has issued a Postal Ballot notice to seek shareholder approval for three key resolutions. These include the issuance of up to 61.90 Crore fully convertible warrants on a preferential basis, an increase in authorized share capital, and related amendments to the Memorandum and Articles of Association.

Vikas Lifecare Annual General Meeting

Vikas Lifecare Limited has issued a postal ballot notice seeking shareholder approval for a ₹99.05 Crore preferential issuance of convertible warrants. Other resolutions include increasing the authorized share capital to ₹300 Crore and altering the Articles of Association. Remote e-voting is scheduled from April 16 to May 15, 2026.

Value

₹99.05 Cr

Execution

18 months

Vikas Lifecare Fund Raise of ₹99.05 Cr

Vikas Lifecare Limited's Fund-Raising Committee approved the preferential issuance of up to 61.91 Crore warrants at ₹1.60 each, aggregating to ₹99.05 Crore. The warrants, convertible into equity shares within 18 months, will be allotted to promoters and public category investors. This capital infusion aims to strengthen the company's financial position for future growth.

Value

₹99.05 Cr

Execution

18 months

Vikas Lifecare Legal & Regulatory

Vikas Lifecare Limited received income tax demand orders totaling ₹22.99 Crore for various assessment years. The demands stem from additions and disallowances made during assessment proceedings. The company is evaluating legal remedies and intends to file appeals, noting no immediate material impact on operations.

Value

₹22.99 Cr

Vikas Lifecare Debt & Borrowing: ₹50 Cr

Vikas Lifecare Limited submitted its initial disclosure under the SEBI Large Corporate framework. The company reported outstanding borrowings of ₹50.00 Crore as of March 31, 2026, and confirmed it does not meet the criteria to be classified as a Large Corporate for the financial year.

Value

₹50.00 Cr

Vikas Lifecare Board Meeting Outcome

Vikas Lifecare's board approved a fund raise of up to ₹200 Crore via equity or warrants. It also proposed increasing the authorized share capital to ₹300 Crore and altering its Articles of Association. These moves aim to support the company's growth strategy for the current fiscal year.

Value

₹200.0 Cr

Vikas Lifecare Board Meeting Outcome

Vikas Lifecare Ltd has scheduled a Board Meeting for April 11, 2026, to deliberate on business growth plans and a proposal for fund raising through the issuance of securities. The trading window for insiders remains closed until 48 hours after the meeting outcome.

Vikas Lifecare Other Announcement

Vikas Lifecare Limited submitted a compliance certificate for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd., confirmed that no dematerialization requests were received from shareholders during this period. This is a routine regulatory disclosure with no material financial impact.